Logo image of SRT3.DE

SARTORIUS AG-VORZUG (SRT3.DE) Stock Price, Quote, News and Overview

FRA:SRT3 - Deutsche Boerse Ag - DE0007165631 - Currency: EUR

214.2  +5.5 (+2.64%)

SRT3.DE Quote, Performance and Key Statistics

SARTORIUS AG-VORZUG

FRA:SRT3 (6/24/2025, 5:36:15 PM)

214.2

+5.5 (+2.64%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High291.9
52 Week Low166.2
Market Cap16.04B
Shares74.88M
Float1.63M
Yearly Dividend0.74
Dividend Yield0.42%
PE50.16
Fwd PE33.76
Earnings (Next)07-22 2025-07-22
IPO04-01 1999-04-01


SRT3.DE short term performance overview.The bars show the price performance of SRT3.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -2 -4

SRT3.DE long term performance overview.The bars show the price performance of SRT3.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of SRT3.DE is 214.2 EUR. In the past month the price decreased by -5.69%. In the past year, price decreased by -4.51%.

SARTORIUS AG-VORZUG / SRT3 Daily stock chart

SRT3.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 17.96 129.44B
DAP.DE DANAHER CORP 25.93 120.42B
LO3.DE LONZA GROUP AG-REG 37.05 42.79B
DIM.PA SARTORIUS STEDIM BIOTECH 52.72 19.50B
56S1.DE SARTORIUS STEDIM BIOTECH 51.97 19.22B
SRT.DE SARTORIUS AG 40.66 13.00B
ILU.DE ILLUMINA INC 26.91 12.36B
ESF0.DE EUROFINS SCIENTIFIC 33.62 11.02B
ERF.PA EUROFINS SCIENTIFIC 33.54 11.00B
QIA.DE QIAGEN N.V. 20.18 8.74B
1SXP.DE SCHOTT PHARMA AG& CO KGAA 29.08 4.29B
EVT.DE EVOTEC SE N/A 2.44B

About SRT3.DE

Company Profile

SRT3 logo image Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,573 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.

Company Info

SARTORIUS AG-VORZUG

Otto-Brenner-Str. 20

Goettingen NIEDERSACHSEN DE

Employees: 13573

SRT3 Company Website

Phone: 495513080

SARTORIUS AG-VORZUG / SRT3.DE FAQ

What is the stock price of SARTORIUS AG-VORZUG today?

The current stock price of SRT3.DE is 214.2 EUR. The price increased by 2.64% in the last trading session.


What is the ticker symbol for SARTORIUS AG-VORZUG stock?

The exchange symbol of SARTORIUS AG-VORZUG is SRT3 and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is SRT3.DE stock listed?

SRT3.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for SARTORIUS AG-VORZUG stock?

7 analysts have analysed SRT3.DE and the average price target is 360.76 EUR. This implies a price increase of 68.42% is expected in the next year compared to the current price of 214.2. Check the SARTORIUS AG-VORZUG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SARTORIUS AG-VORZUG worth?

SARTORIUS AG-VORZUG (SRT3.DE) has a market capitalization of 16.04B EUR. This makes SRT3.DE a Large Cap stock.


How many employees does SARTORIUS AG-VORZUG have?

SARTORIUS AG-VORZUG (SRT3.DE) currently has 13573 employees.


What are the support and resistance levels for SARTORIUS AG-VORZUG (SRT3.DE) stock?

SARTORIUS AG-VORZUG (SRT3.DE) has a support level at 204.15 and a resistance level at 209.51. Check the full technical report for a detailed analysis of SRT3.DE support and resistance levels.


Is SARTORIUS AG-VORZUG (SRT3.DE) expected to grow?

The Revenue of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 6.37% in the next year. Check the estimates tab for more information on the SRT3.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SARTORIUS AG-VORZUG (SRT3.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SARTORIUS AG-VORZUG (SRT3.DE) stock pay dividends?

SARTORIUS AG-VORZUG (SRT3.DE) has a dividend yield of 0.42%. The yearly dividend amount is currently 0.74. Check the full fundamental report for a detailed analysis of SRT3.DE dividend history, reliability and sustainability.


When does SARTORIUS AG-VORZUG (SRT3.DE) report earnings?

SARTORIUS AG-VORZUG (SRT3.DE) will report earnings on 2025-07-22.


What is the Price/Earnings (PE) ratio of SARTORIUS AG-VORZUG (SRT3.DE)?

The PE ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 50.16. This is based on the reported non-GAAP earnings per share of 4.27 and the current share price of 214.2 EUR. Check the full fundamental report for a full analysis of the valuation metrics for SRT3.DE.


SRT3.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SRT3.DE. When comparing the yearly performance of all stocks, SRT3.DE is a bad performer in the overall market: 78.55% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SRT3.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE. SRT3.DE has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SRT3.DE Financial Highlights

Over the last trailing twelve months SRT3.DE reported a non-GAAP Earnings per Share(EPS) of 4.27. The EPS decreased by -36.23% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.77%
ROA 0.94%
ROE 3.52%
Debt/Equity 1.55
Chartmill High Growth Momentum
EPS Q2Q%30.97%
Sales Q2Q%7.74%
EPS 1Y (TTM)-36.23%
Revenue 1Y (TTM)3.99%

SRT3.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 77% to SRT3.DE. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 22.89% and a revenue growth 6.37% for SRT3.DE


Ownership
Inst Owners4.37%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts77.14
Price Target360.76 (68.42%)
EPS Next Y22.89%
Revenue Next Year6.37%